Viz.ai Raises $100M serial D Funding

Viz.ai Raises $100M serial D Funding
Viz.ai Raises $100M serial D Funding

Viz.ai, a San Francisco, CA, and Tel Aviv, Israel and -based AI-powered disease detection and care coordination platform, raised a $100m serial D funding round at a $1.2 billion valuation.

The round was led by Tiger Global and Insight Partners with participation from early backers, including Scale Ventures, Kleiner Perkins, Threshold, GV (formerly Google Ventures), Sozo Ventures, CRV, and Susa.

The company intends to use the new funds to expand the platform to detect and triage additional diseases and grow its customer base globally.

Led by Chris Mansi, MD, co-founder, and CEO, Viz.ai leverages AI algorithms and machine learning to extend the speed of diagnosis and care for a variety of acute and emergent diseases across hospitals and health systems. The intelligent care coordination solution unifies synchronized care collaboration, hi-fi mobile image viewing, automated workflows, and improved visibility at decision-making moments. Viz.ai’s comprehensive neurovascular and vascular AI platform is clinically proven to save lots of time and improve patient outcomes and access to care and is used in more than 1,000 hospitals within the US and EMEA. Customers include Sinai Health System, Jefferson University, Banner Health, CommonSpirit Health, and HCA Healthcare, which is additionally an investor.

The company is located in San Francisco, Tel Aviv, Portugal, and Amsterdam.

Leave a Reply

Your email address will not be published.

Related Posts

Lewdweb

Are you looking for information about Lewdweb? You have come to the right place! In this blog post,…
amazon
Read More

amazon

Are you looking for information on amazon? You have come to the right place! In this blog post,…